Inactive Instrument

Calendar Miragen Therapeutics Inc Nasdaq

Equities

US8266402036

End-of-day quote Nasdaq
- USD - Intraday chart for Miragen Therapeutics Inc

Chart calendar Miragen Therapeutics Inc

207d44361fbb7e2ad610e35a2bf29._M5-NyEWY5ztTtz_goTFYeO1Tc82JCTdIJk4kf0Ub1U.m4sNVVdPL6q0BI-esfCIGZvjN6obCWHqZP5wxLl6HQ_KoxwHVlcs-4IWhQ~af123b02d98e86a637ec61e97a564709

Upcoming events on Miragen Therapeutics Inc

06/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)
12/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Miragen Therapeutics Inc

17/06/2024 20:00 Annual General Meeting
11/06/2024 13:40 Goldman Sachs Global Healthcare Conference
05/06/2024 22:00 Jefferies Global Healthcare Conference
16/05/2024 00:35 BofA Securities Health Care Conference
14/05/2024 13:30 RBC Capital Markets Global Healthcare Conference
08/05/2024 13:00 Q1 2024 Earnings Call
08/05/2024 12:00 Q1 2024 Earnings Release
11/03/2024 18:00 Leerink Partners Global Biopharma Conference
05/03/2024 20:15 North American Neuro Ophthalmology Society Meeting
05/03/2024 17:00 North American Neuro Ophthalmology Society Meeting
11/01/2024 15:30 JPMorgan Healthcare Conference
18/12/2023 13:00 VRDN-003 IGF-1R Clinical Trial Results Call
30/11/2023 16:15 Evercore ISI HealthCONx Conference
15/11/2023 16:00 Jefferies London Healthcare Conference - Fireside Chat
13/11/2023 21:01 Q3 2023 Earnings Release
05/11/2023 23:45 American Academy of Ophthalmology Meeting
04/11/2023 16:45 American Academy of Ophthalmology Meeting
02/11/2023 American Academy Of Ophthalmology Meeting
28/09/2023 18:50 American Thyroid Association Meeting
16/09/2023 08:35 European Society of Ophthalmic Plastic and Reconstructive Surgery Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,46
4,32
3.38%
1,05
1,05
0.42%
2,96
3,12
-5.11%
1,77
2,13
-16.98%
0,31
0,39
-18.44%

0,35

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-65,1
-58,8
-10.86%
-134
-105
-28.12%
-187
-184
-1.58%

-187

EBIT
Million USD
Released
Forecast
Spread
-42,0
-41,5
-1.26%
-110
-26,4
-318.14%
-79,7
-68,4
-16.63%
-134
-116
-15.74%
-254
-238
-7.09%

-256

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-41,9
-41,3
-1.39%
-111
-26,9
-311.37%
-79,4
-68,2
-16.47%
-130
-114
-14.34%
-238
-224
-6.2%

-235

Net income
Million USD
Released
Forecast
Spread
-41,9
-41,3
-1.39%
-111
-26,7
-315.12%
-79,4
-68,7
-15.61%
-130
-115
-13.26%
-238
-224
-6.32%

-230

EPS
USD
Released
Forecast
Spread
-20,1
-17,1
-17.34%
-31,1
-3,18
-879.55%
-6,68
-6,42
-4.08%
-4,05
-3,57
-13.52%
-5,31
-4,94
-7.46%

-3,71

Announcement Date11/03/2026/03/2110/03/2208/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,22
0,25
-14.79%
0,26
0,23
10.48%
1,20
0,26
359.62%
0,11
0,46
-77.05%
0,10
0,00
-
0,07
0,20
-63.18%
0,07
0,10
-29.01%
0,07
0,15
-53.3%
0,07
0,08
-9.81%

0,09


0,09


0,12


0,12


0,12

EBITDA
Million USD
Released
Forecast
Spread
-21,2
-19,5
-8.71%
-24,6
-20,1
-22.41%
-24,8
-25,3
1.81%
-49,0
-26,2
-87.16%
-57,2
-37,0
-54.46%
-46,8
-31,5
-48.7%
-51,1
-43,5
-17.45%
-45,3
-42,0
-7.81%
-43,1
-33,6
-28.03%

-46,9


-50,9


-54,0







EBIT
Million USD
Released
Forecast
Spread
-25,9
-23,2
-11.36%
-29,6
-25,2
-17.1%
-29,8
-30,9
3.62%
-49,1
-30,8
-59.09%
-72,5
-47,1
-54.03%
-59,3
-54,1
-9.56%
-51,2
-58,2
11.99%
-71,5
-54,7
-30.77%
-55,9
-67,0
16.58%

-63,5


-66,1


-70,4


-68,0


-80,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,7
-23,6
-8.75%
-29,5
-24,9
-18.5%
-28,9
-29,3
1.3%
-45,8
-29,5
-55.18%
-68,2
-43,7
-56.13%
-55,1
-48,2
-14.16%
-47,7
-54,9
13.23%
-66,9
-51,3
-30.34%
-48,5
-61,1
20.61%

-58,9


-61,6


-66,3


-70,7


-72,9

Net income
Million USD
Released
Forecast
Spread
-25,7
-24,5
-4.82%
-29,5
-25,4
-16.3%
-28,9
-30,8
6.06%
-45,8
-30,3
-51.03%
-68,2
-46,9
-45.39%
-55,1
-53,3
-3.32%
-47,7
-54,2
12.11%
-66,9
-51,8
-29.17%
-48,5
-62,5
22.3%

-57,1


-61,0


-63,8


-70,7


-72,9

EPS
USD
Released
Forecast
Spread
-0,98
-1,00
2%
-1,06
-0,89
-19.55%
-0,86
-0,98
12.5%
-1,13
-0,73
-54.79%
-1,61
-0,96
-68.29%
-1,27
-1,24
-2.27%
-1,09
-1,24
11.88%
-1,35
-1,01
-34.22%
-0,79
-1,07
26.23%

-0,90


-0,96


-0,99


-0,99


-1,02

Announcement Date12/05/2215/08/2214/11/2208/03/2310/05/2308/08/2313/11/2327/02/2408/05/24-----
  1. Stock Market
  2. Equities
  3. VRDN Stock
  4. Stock
  5. Calendar Miragen Therapeutics Inc